Dawei Yang

833 total citations
16 papers, 626 citations indexed

About

Dawei Yang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Dawei Yang has authored 16 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Dawei Yang's work include Immune cells in cancer (3 papers), Cancer Mechanisms and Therapy (2 papers) and Epigenetics and DNA Methylation (2 papers). Dawei Yang is often cited by papers focused on Immune cells in cancer (3 papers), Cancer Mechanisms and Therapy (2 papers) and Epigenetics and DNA Methylation (2 papers). Dawei Yang collaborates with scholars based in China, United States and Canada. Dawei Yang's co-authors include Na Lu, Binyan Lin, Xiuming Song, Y. Ding, Xingling Yi, Jie Yin, Wei Zhang, Tao Wu, Qinglong Guo and Xiaoyu Tian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Biochemical Pharmacology.

In The Last Decade

Dawei Yang

14 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawei Yang China 9 284 274 150 117 76 16 626
Jianping Wang China 17 311 1.1× 164 0.6× 105 0.7× 145 1.2× 90 1.2× 39 661
Suk‐young Lee South Korea 16 395 1.4× 216 0.8× 111 0.7× 148 1.3× 46 0.6× 43 719
Wei Jing China 16 341 1.2× 269 1.0× 199 1.3× 111 0.9× 68 0.9× 45 694
Colin Rae United Kingdom 17 309 1.1× 200 0.7× 92 0.6× 226 1.9× 83 1.1× 27 636
Kelly Su Taiwan 6 287 1.0× 184 0.7× 139 0.9× 113 1.0× 38 0.5× 7 553
Liuxin Cai China 10 381 1.3× 208 0.8× 157 1.0× 205 1.8× 146 1.9× 18 712
Aswin Abraham Canada 11 376 1.3× 205 0.7× 98 0.7× 136 1.2× 91 1.2× 30 718
Kyoung Eun Baek South Korea 13 432 1.5× 218 0.8× 69 0.5× 109 0.9× 46 0.6× 18 633
Sandra F. Martins Portugal 12 301 1.1× 224 0.8× 104 0.7× 223 1.9× 126 1.7× 39 627

Countries citing papers authored by Dawei Yang

Since Specialization
Citations

This map shows the geographic impact of Dawei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Yang more than expected).

Fields of papers citing papers by Dawei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Yang. The network helps show where Dawei Yang may publish in the future.

Co-authorship network of co-authors of Dawei Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Dawei Yang. A scholar is included among the top collaborators of Dawei Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawei Yang. Dawei Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
3.
Shao, Xinyi, Dawei Yang, Lei Li, et al.. (2024). TH-4000, a hypoxia-activated pan-HER inhibitor, shows excellent preclinical efficacy for the treatment of HER2+ breast cancer. Archives of Toxicology. 98(3). 865–881. 1 indexed citations
4.
Zhao, Kai, Zhenzhong Chen, Jinming Yang, et al.. (2024). Nerve Growth Factor Signaling Promotes Nuclear Translocation of TRAF4 to Enhance Tumor Stemness and Metastatic Dormancy Via C‐Jun‐mediated IL‐8 Autocrine. Advanced Science. 12(7). e2414437–e2414437. 3 indexed citations
5.
Peng, Qiaoli, Runhong Zhou, Na Liu, et al.. (2022). Naturally occurring spike mutations influence the infectivity and immunogenicity of SARS-CoV-2. Cellular and Molecular Immunology. 19(11). 1302–1310. 17 indexed citations
6.
Yang, Dawei, et al.. (2022). Identification of lysine-lactylated substrates in gastric cancer cells. iScience. 25(7). 104630–104630. 91 indexed citations
7.
Yang, Dawei, et al.. (2022). MIoT integrates health, MM benefits humans. SHILAP Revista de lepidopterología. 5. 17–18. 7 indexed citations
8.
Yang, Dawei, et al.. (2021). Identification of GL-V9 as a novel senolytic agent against senescent breast cancer cells. Life Sciences. 272. 119196–119196. 37 indexed citations
9.
Zhao, Cen, et al.. (2021). Inhibition of Pim-2 kinase by LT-171-861 promotes DNA damage and exhibits enhanced lethal effects with PARP inhibitor in multiple myeloma. Biochemical Pharmacology. 190. 114648–114648. 4 indexed citations
10.
Yang, Dawei, Qinglong Guo, Yue Zhao, et al.. (2020). Wogonin induces cellular senescence in breast cancer via suppressing TXNRD2 expression. Archives of Toxicology. 94(10). 3433–3447. 53 indexed citations
11.
Lin, Binyan, Kai Zhao, Dawei Yang, et al.. (2018). Wogonoside impedes the progression of acute myeloid leukemia through inhibiting bone marrow angiogenesis. Journal of Cellular Physiology. 234(2). 1913–1924. 11 indexed citations
12.
Lin, Binyan, et al.. (2018). Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1. Gene. 654. 77–86. 289 indexed citations
13.
Zhao, Kai, Xiaorui Li, Binyan Lin, et al.. (2017). Oroxyloside inhibits angiogenesis through suppressing internalization of VEGFR2/Flk‐1 in endothelial cells. Journal of Cellular Physiology. 233(4). 3454–3464. 18 indexed citations
14.
Yang, Dawei, et al.. (2015). P15, MDM2, NF-κB, and Bcl-2 expression in primary bone tumor and correlation with tumor formation and metastasis.. PubMed. 8(11). 14885–92. 4 indexed citations
15.
Brune, Kieran, Seung‐Mo Hong, Ang Li, et al.. (2008). Genetic and Epigenetic Alterations of Familial Pancreatic Cancers. Cancer Epidemiology Biomarkers & Prevention. 17(12). 3536–3542. 66 indexed citations
16.
Yang, Dawei, Yasuhiro Ohta, Shinya Yamaguchi, et al.. (1996). Sulfated colominic acid: an antiviral agent that inhibits the human immunodeficiency virus type 1 in vitro. Antiviral Research. 31(1-2). 95–104. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026